BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 16094643)

  • 21. Cancer/testis antigen expression and autologous humoral immunity to NY-ESO-1 in gastric cancer.
    Wang Y; Wu XJ; Zhao AL; Yuan YH; Chen YT; Jungbluth AA; Gnjatic S; Santiago D; Ritter G; Chen WF; Old LJ; Ji JF
    Cancer Immun; 2004 Nov; 4():11. PubMed ID: 15516106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
    Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA
    Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis of CT antigen expression and humoral immunogenicity of NY-ESO-1 protein in gastric carcinoma].
    Wu XJ; Wang Y; Ji JF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 37(3):252-6. PubMed ID: 15968313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
    Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M
    Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells.
    Rentzsch C; Kayser S; Stumm S; Watermann I; Walter S; Stevanoviç S; Wallwiener D; Gückel B
    Clin Cancer Res; 2003 Oct; 9(12):4376-86. PubMed ID: 14555509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparisons for detecting NY-ESO-1 mRNA expression levels in hepatocellular carcinoma tissues.
    Wang XY; Chen HS; Luo S; Zhang HH; Fei R; Cai J
    Oncol Rep; 2009 Mar; 21(3):713-9. PubMed ID: 19212631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of serologically identified tumor antigens in acute leukemias.
    Niemeyer P; Türeci O; Eberle T; Graf N; Pfreundschuh M; Sahin U
    Leuk Res; 2003 Jul; 27(7):655-60. PubMed ID: 12681366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of cancer/testis antigens in cutaneous T cell lymphomas.
    Häffner AC; Tassis A; Zepter K; Storz M; Tureci O; Burg G; Nestle FO
    Int J Cancer; 2002 Feb; 97(5):668-70. PubMed ID: 11807795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer.
    Sharma P; Gnjatic S; Jungbluth AA; Williamson B; Herr H; Stockert E; Dalbagni G; Donat SM; Reuter VE; Santiago D; Chen YT; Bajorin DF; Old LJ
    Cancer Immun; 2003 Dec; 3():19. PubMed ID: 14680360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple cancer/testis antigens are preferentially expressed in hormone-receptor negative and high-grade breast cancers.
    Chen YT; Ross DS; Chiu R; Zhou XK; Chen YY; Lee P; Hoda SA; Simpson AJ; Old LJ; Caballero O; Neville AM
    PLoS One; 2011 Mar; 6(3):e17876. PubMed ID: 21437249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequent expression of HAGE in presentation chronic myeloid leukaemias.
    Adams SP; Sahota SS; Mijovic A; Czepulkowski B; Padua RA; Mufti GJ; Guinn BA
    Leukemia; 2002 Nov; 16(11):2238-42. PubMed ID: 12399967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer.
    Groeper C; Gambazzi F; Zajac P; Bubendorf L; Adamina M; Rosenthal R; Zerkowski HR; Heberer M; Spagnoli GC
    Int J Cancer; 2007 Jan; 120(2):337-43. PubMed ID: 17066423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PDIA3 and PDIA6 gene expression as an aggressiveness marker in primary ductal breast cancer.
    Ramos FS; Serino LT; Carvalho CM; Lima RS; Urban CA; Cavalli IJ; Ribeiro EM
    Genet Mol Res; 2015 Jun; 14(2):6960-7. PubMed ID: 26125904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance.
    Yoshida N; Abe H; Ohkuri T; Wakita D; Sato M; Noguchi D; Miyamoto M; Morikawa T; Kondo S; Ikeda H; Nishimura T
    Int J Oncol; 2006 May; 28(5):1089-98. PubMed ID: 16596224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequent expression of the novel cancer testis antigen MAGE-C2/CT-10 in hepatocellular carcinoma.
    Riener MO; Wild PJ; Soll C; Knuth A; Jin B; Jungbluth A; Hellerbrand C; Clavien PA; Moch H; Jochum W
    Int J Cancer; 2009 Jan; 124(2):352-7. PubMed ID: 18942708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential target antigens for immunotherapy in human pancreatic cancer.
    Schmitz-Winnenthal FH; Galindo-Escobedo LV; Rimoldi D; Geng W; Romero P; Koch M; Weitz J; Krempien R; Niethammer AG; Beckhove P; Buchler MW; Z'graggen K
    Cancer Lett; 2007 Jul; 252(2):290-8. PubMed ID: 17320278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of prognostic significance of survivin, survivin-deltaEx3, survivin-2B, galectin-3, bag-1, bax-alpha and MRP-1 mRNAs in breast cancer.
    O'Driscoll L; Linehan R; M Kennedy S; Cronin D; Purcell R; Glynn S; W McDermott E; D Hill A; J O'Higgins N; Parkinson M; Clynes M
    Cancer Lett; 2003 Nov; 201(2):225-36. PubMed ID: 14607338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of cancer-testis antigen (CTA) genes in intrahepatic cholangiocarcinoma.
    Utsunomiya T; Inoue H; Tanaka F; Yamaguchi H; Ohta M; Okamoto M; Mimori K; Mori M
    Ann Surg Oncol; 2004 Oct; 11(10):934-40. PubMed ID: 15466353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polo-like kinase: a novel marker of proliferation: correlation with estrogen-receptor expression in human breast cancer.
    Wolf G; Hildenbrand R; Schwar C; Grobholz R; Kaufmann M; Stutte HJ; Strebhardt K; Bleyl U
    Pathol Res Pract; 2000; 196(11):753-9. PubMed ID: 11186170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer-germline gene expression in pediatric solid tumors using quantitative real-time PCR.
    Jacobs JF; Brasseur F; Hulsbergen-van de Kaa CA; van de Rakt MW; Figdor CG; Adema GJ; Hoogerbrugge PM; Coulie PG; de Vries IJ
    Int J Cancer; 2007 Jan; 120(1):67-74. PubMed ID: 17019710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.